SecurityGSK / GlaxoSmithKline plc
InstitutionLetko, Brosseau & Associates Inc
Shares1,031,358
Value $ 41,574,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Letko, Brosseau & Associates Inc reports 1.35% decrease in ownership of GSK / GlaxoSmithKline plc

August 07, 2018 - Letko, Brosseau & Associates Inc has filed a 13F-HR form disclosing ownership of 1,031,358 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $41,574,000 USD as of June 30, 2018. Letko, Brosseau & Associates Inc had filed a previous 13F-HR on May 08, 2018 disclosing 1,045,463 shares of GlaxoSmithKline plc at a value of $40,846,000 USD. This represents a change in shares of -1.35 percent and a change in value of 1.78 percent during the quarter.

Other investors with positions similar to Letko, Brosseau & Associates Inc include Primecap Management Co/ca/, Two Sigma Advisers, Lp, Kornitzer Capital Management Inc /ks, Pnc Financial Services Group, Inc., Mondrian Investment Partners LTD, and GW&K Investment Management, LLC.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.69 1,031,358 -1.35 41,574 1.78 -560 1,288 3.15
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 37.27 1,045,463 1.73 40,846 12.05 662 3,732 10.24
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.03 1,027,688 3.01 36,452 -10.01 1,141 -5,195 -12.83
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.86 997,688 0.47 40,506 -5.41 194 -2,509 -5.86
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 42.64 993,063 -1.45 42,821 0.80 -621 960 2.26
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.33 1,007,638 -1.13 42,482 8.24 -466 3,699 9.43
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.82 1,019,198 -4.32 39,249 -14.57 -1,880 -4,815 -10.48
2016-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.23 1,065,243 -2.24 45,944 -2.72 -1,057 -226 -0.48
2016-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.94 1,089,693 -1.32 47,227 5.47 -610 3,060 6.83
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.45 1,104,243 -3.72 44,777 -3.25 -1,727 225 0.49
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.40 1,146,943 -3.97 46,279 0.78 -1,869 2,225 4.84
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.05 1,194,368 -1.28 45,923 -8.86 -620 -3,847 -7.63
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.90 1,209,853 9.55 50,390 -1.14 4,629 -5,208 -10.22
2015-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 44.44 1,104,413 0.91 50,969 8.96 442 3,750 8.02
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 44.35 1,094,463 5,469.79 46,777 5,080.18 47,665 -1,791 -198.30
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 49.72 19,650 0.00 903 -14.08 0 -148 -14.08
2014-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 19,650 1,051


CUSIP: 37733W105